M
$ Value
—
Shares
9,935
Price
—
Filed
Jun 16
Insider
Name
Pendarvis Christiane
Title
—
CIK
0001965920
Roles
Director
Transaction Details
Transaction Date
2025-06-12
Code
M
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
36,563
Footnotes
The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2025 annual meeting of stockholders or (b) June 15, 2025.
Filing Info
Pendarvis Christiane's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-13 | HIMS | M | — |
| 2026-03-13 | HIMS | M | $0 |
| 2025-08-06 | HIMS | A | $0 |
| 2025-06-12 | HIMS | M | — |
| 2025-06-12 | HIMS | M | $0 |
Other Insiders at HIMS (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Dudum Andrew
Chief Executive Officer
|
— | — | 2026-04-09 |
|
Boughton Soleil
Chief Legal Officer
|
— | $473K | 2026-04-20 |
|
Carroll Patrick Harrison
Chief Medical Officer
|
— | — | 2026-03-13 |
|
Autor Deborah M.
Chief Policy Officer
|
— | — | 2026-03-13 |
|
Becklund Irene
PAO
|
— | $137K | 2026-03-17 |
|
Okupe Oluyemi
Chief Financial Officer
|
— | $2.5M | 2026-04-20 |
|
Chi Michael
Chief Operating Officer
|
— | $2.4M | 2026-03-17 |
| Pendarvis Christiane | — | — | 2026-03-13 |
|
Elshenawy Mohamed
CTO
|
— | — | 2026-03-11 |